Document:

QuickLinks
 -- Click here to rapidly navigate through this document
  

 
 

Exhibit 10.32    
    

September 28,
2007 

Gregory
Marsh

c/o PDS Heart, Inc.

1801 Centrepark Drive East, #110

West Palm Beach, FL 33401 

Dear
Greg: 

This
letter sets forth the substance of the separation agreement (the "Agreement") that CardioNet, Inc. ("CardioNet" or the "Company") is offering to you to aid in your employment transition. 

        1.    Separation.    Your last day of work as the Chief Financial
Officer of CardioNet will be September 27, 2007, and your last day of work as the Chief Operating Officer of PDS Heart, Inc., a wholly owned subsidiary of the Company ("PDS"), will be
October 26, 2007 (the "Separation Date"). You will be expected to continue to report to work and perform services as requested through the Separation Date. 

        2.    Accrued Salary And Paid Time Off.    On the Separation Date, the
Company will pay you all accrued salary, and all accrued and unused vacation time earned through the Separation Date, subject to standard payroll deductions and withholdings. You are entitled to these
payments by law. 

        3.    Stock Options.    Under the terms of your stock option agreement
and the applicable plan documents, none of your stock options will have vested as of the Separation Date. In consideration for your continued employment as the Chief Operating Officer of PDS from
September 28, 2007 through the Separation Date and the confidentiality and nondisparagement benefits provided in Sections 9 and 10
herein, you hereby agree that, notwithstanding anything to the contrary in the applicable stock option agreements, stock option grant notices or governing plan documents, (i) you may not
exercise any of your Company stock options following your execution of this Agreement, and (ii) all of your Company stock options will be automatically cancelled effective as of the date you
execute this Agreement, and you will not have any rights with respect to such options following such date. You acknowledge and agree that this Section 3 will become effective immediately upon
your execution of this Agreement and may not be revoked. 

        4.    Severance Benefits and General Release.    

        4.1    Severance Benefits.    If (1) you sign this Agreement
and allow the general release and waiver of claims included in Sections 4.2, 4.3 and 4.4 herein to become effective; and (2) on October 18, 2007, you execute the general release and
waiver of claims attached hereto as Exhibit A (the "10/18/07 Release") and allow it to become effective, then, pursuant to your Employment and Non-Competition Agreement with PDS
dated January 1, 2007 (the "Employment and Non-Competition Agreement"), as modified and adopted by CardioNet in the February 2, 2007 letter agreement between you and
CardioNet (the "2/2/07 Letter Agreement"), you will be entitled to the following (the "Severance Benefits"): 

        (a)   a
severance payment equal to 18 months of your base salary in effect as of the Separation Date (or $409,500.00), subject to standard payroll deductions and
withholdings (the "Severance Payment"). The Severance Payment will be paid to you in a lump sum within ten (10) days after the effective date of the 10/18/07 Release (as defined therein); and 

        (b)   if
you are eligible for and timely elect continued coverage under COBRA, then the Company will pay your COBRA premiums at the same level of coverage elected as of the
Separation Date, including vision and dental coverage, for a period of 18 months following the effective date of the 10/18/07 Release (as defined therein), provided, however, that any such 

1

 

payments
will cease if you voluntarily enroll in a health insurance plan offered by another employer or entity during the period in which the Company is paying such premiums. You agree to immediately
notify the Company in writing of any such enrollment. 

        4.2    Release of Claims.    In exchange for the Company's agreement
to pay you the Severance Benefits if you comply with the conditions specified in Section 4.1 above, you hereby generally and completely release the Company and its directors, officers,
employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns from any and all claims, liabilities and obligations,
both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring at any time prior to and including the date you sign this Agreement (the
"Release"). Notwithstanding the foregoing, you are not releasing: (a) any right you may have to indemnification by the Company under any valid written agreement, the articles or
by-laws of the Company, insurance policy, or applicable law, (b) any right to accrued benefits or compensation, including any accrued salary or accrued and unused vacation time, or
(c) any right under the Employment and Non-Competition Agreement or 2/2/07 Letter Agreement. 

        4.3    ADEA Waiver.    You acknowledge that, in exchange for the
Company's agreement to pay you the Severance Benefits if you comply with the conditions specified in Section 4.1 above, you are knowingly and voluntarily waiving and releasing any rights you
may have under the ADEA ("ADEA Waiver"). You also acknowledge that the consideration given for the ADEA Waiver is in addition to anything of value to which you were already entitled. You are advised
by this writing, as required by the ADEA, that: (a) this Release does not apply to any claims that may arise after you sign this Agreement; (b) you should consult with an attorney prior
to executing this Release; (c) you have twenty-one (21) days within which to consider this Release (although you may choose to voluntarily execute this Release earlier);
(d) you have seven (7) days following the execution of this Release to revoke the Release; and (e) this Release will not be effective until the eighth day after you sign it,
provided that you have not earlier revoked this Release (the "Effective Date"). Your allowing this Release to become effective is a condition precedent to you receiving any of the Severance Benefits.
You understand and agree that all of the provisions of this Agreement other than the Release contained in Sections 4.2, 4.3, and 4.4 herein will become immediately effective and irrevocable as of the
date you sign this Agreement, and will not be affected if you revoke this Release. 

        4.4    Section 1542 Waiver.    In granting the Release, which
includes claims that may be unknown to you at present, you acknowledge that you have read and understand Section 1542 of the California Civil Code: "A general release
does not extend to claims that the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his
or her settlement with the debtor." You hereby expressly waive and relinquish all rights and benefits under that section and any law or legal principle of similar effect in any
jurisdiction with respect to the releases granted herein, including but not limited to the release of unknown and unsuspected claims granted in this Agreement. 

        5.    Other Compensation Or Benefits.    You acknowledge that, except
as expressly provided in this Agreement, you will not receive any additional compensation, severance, or benefits after the Separation Date. 

        6.    Expense Reimbursements.    You agree that, following the
Separation Date, you will submit your final documented expense reimbursement statement reflecting all business expenses incurred through the Separation Date for which you seek reimbursement. You agree
to submit this statement as soon as practicable, but in no event later than December 15, 2007. The Company will reimburse you for these expenses pursuant to its regular business practice. 

2

 

        7.    Return Of Company Property.    By the Separation Date, you agree
to return to the Company all Company documents (and all copies thereof) and other Company property that you have in your possession, custody, or control, including, but not limited to, Company files,
notes, drawings, records, business plans and forecasts, financial information, specifications, computer-recorded information, tangible property (including, but not limited to, computers), credit
cards, entry cards, identification badges, and keys; and, any materials of any kind that contain or embody any proprietary or confidential information of the Company (and all reproductions thereof).
Your timely return of all such Company documents and other property is a condition precedent to your receipt of the severance benefits provided under this Agreement. 

        8.    Continuing Obligations.    You acknowledge your continuing
obligations under the Restrictive Covenants contained in your Employment and Non-Competition Agreement and under your Non-Competition, Non-Solicitation and
No-Hire Agreement with CardioNet dated February 4, 2007 (the "CardioNet Non-Competition Agreement"). Your continued adherence to the Restrictive Covenants in the
Employment and Non-Competition Agreement and to the terms of the CardioNet Non-Competition Agreement is a condition precedent to your receipt of severance benefits as provided
under this Agreement. 

        9.    Confidentiality.    The provisions of this Agreement will be
held in strictest confidence by you and the Company and will not be publicized or disclosed in any manner whatsoever; provided, however, that:
(a) you may disclose this Agreement in confidence to your immediate family; (b) the parties may disclose this Agreement in confidence to their respective attorneys, accountants,
auditors, tax preparers, and financial advisors; (c) the Company may disclose this Agreement as necessary to fulfill standard or legally required corporate reporting or disclosure requirements;
and (d) the parties may disclose this Agreement insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law. In particular, and without limitation, you
agree not to disclose the terms of this Agreement to any current or former Company employee. 

        10.    Nondisparagement.    Both you and the Company's officers,
directors and managers agree not to disparage the other party or parties, or their officers, directors, managers, employees, members, agents, or affiliates in any manner likely to be harmful to them
or their business, business reputation or personal reputation, provided that both you and the Company may respond accurately and fully to any inquiry or request for information if required by legal
process. 

        11.    No Admissions.    You understand and agree that the promises
and payments in consideration of this Agreement shall not be construed to be an admission of any liability or obligation by the Company to you or to any other person, and that the Company makes no
such admission. 

        12.    Miscellaneous.    This Agreement, along with Exhibit A,
the CardioNet Non-Competition Agreement, any surviving portions of the Employment and Non-Competition Agreement and the 2/2/07 Letter Agreement, and the Release and Waiver of
Claims in favor of the Company that you signed on March 1, 2007, constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to its
subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises,
warranties or representations. This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of the Company. This Agreement will bind the heirs,
personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. If any provision of this
Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question will be modified so
as to be rendered enforceable. This Agreement will be deemed to have been entered into and will be construed and enforced in accordance with the laws of the State of Florida as applied to contracts
made and to be performed entirely within Florida. Any ambiguity in this 

3

 

Agreement
shall not be construed against either party as the drafter. Any waiver of a breach of this Agreement shall be in writing and shall not be deemed to be a waiver of any successive breach. This
Agreement may be executed in counterparts and facsimile signatures will suffice as original signatures. 

If
this Agreement is acceptable to you, please sign below and return the original to me. 

We
wish you the best in your future endeavors. 

Sincerely,

	CARDIONET, INC.	 	 
	

 	
 	

 	
 	

 
	By:	 	/s/  JAMES M. SWEENEY    

    James M. Sweeney

    Chairman and CEO	 	 

I HAVE READ, UNDERSTAND AND AGREE FULLY TO THE FOREGOING AGREEMENT:

	

/s/  GREGORY MARSH      
GREGORY MARSH	
 	

 
	

Date:	
 	

9/28/2007	
 	

 

4

 
 
 

EXHIBIT A
  
    RELEASE AND WAIVER OF CLAIMS
  
    TO BE SIGNED ON THE SEPARATION DATE    
    

        In consideration of the Severance Benefits set forth in my separation agreement with CardioNet, Inc. (the "Company") dated September 28, 2007 (the
"Separation Agreement"), to which this form is attached, I, Gregory Marsh, hereby the Company with the following general release and waiver of claims (the "Release"). 

        Pursuant
to the Employment and Non-Competition Agreement dated January 1, 2007 between me and PDS Heart, Inc., a wholly owned subsidiary of the Company, as
modified and adopted by the Company in the February 2, 2007 letter agreement between me and the Company, and in exchange for the Severance Benefits, I hereby generally and completely release
the Company and its directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns from any and
all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring at any time prior to and including the
date I sign this Release. This Release includes, but is not limited to: (a) all claims arising out of or in any way related to my
employment with the Company, the termination of that employment, the Employment and Non-Competition Agreement, the 2/2/07 Letter Agreement, and/or the CardioNet Non-Competition
Agreement; (b) all claims related to my compensation or benefits from the Company, including salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits,
stock, stock options, or any other ownership interests in the Company; (c) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair
dealing; (d) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (e) all federal, state, and local statutory
claims, including claims for discrimination, harassment, retaliation, attorneys' fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with
Disabilities Act of 1990, the federal Age Discrimination in Employment Act of 1967, as amended ("ADEA"), the California Fair Employment and Housing Act (as amended), the Florida Wage Discrimination
Law, and the Florida Civil Rights Act. Notwithstanding the foregoing, I am not releasing any right I may have to indemnification by the Company under any valid written agreement, the articles or
by-laws of the Company, insurance policy, or applicable law. 

        I
acknowledge that, in exchange for the Severance Benefits, I am knowingly and voluntarily waiving and releasing any rights I may have under the ADEA ("ADEA Waiver"). I also acknowledge
that the consideration given for the ADEA Waiver is in addition to anything of value to which I was already entitled. I am advised by this writing, as required by the ADEA, that: (a) my waiver
and release does not apply to any claims that may arise after I sign this Agreement; (b) I should consult with an attorney prior to executing this release; (c) I have
twenty-one (21) days within which to consider this release (although I may choose to voluntarily execute this release earlier); (d) I have seven (7) days following the
execution of this release to revoke this Release; and (e) this Release will not be effective until the eighth day after I sign it, provided that I have not earlier revoked this Release (the
"Effective Date"). I will not be entitled to receive any of the Severance Benefits unless and until this Release becomes effective. 

        I
also acknowledge that I have read and understand Section 1542 of the California Civil Code which reads as follows: "A general release does not extend to
claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement
with the debtor." I hereby expressly waive and relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to any
claims I may have against the Company. 

5

 

        This
Release constitutes the complete, final and exclusive embodiment of the entire agreement between the Company and me with regard to the subject matter hereof. I am not relying on any
promise or representation by the Company that is not expressly stated herein. This Release may only be modified by a writing signed by both me and a duly authorized officer of the Company. 

	

Date:	
 	

9/28/2007	
 	

By:	
 	

/s/  GREGORY MARSH      
 Gregory Marsh

6

QuickLinks

Exhibit 10.32

EXHIBIT A RELEASE AND WAIVER OF CLAIMS TO BE SIGNED ON THE SEPARATION DATEFiled by Automated Filing Services Inc. (604) 609-0244 - Canyon Copper Corp. - Exhibit 10.1

THIRD AMENDMENT TO LOAN AGREEMENT

This Third Amendment to the Loan Agreement dated September 12,
2006, as amended on November 27, 2006 and April 12, 2007, (collectively, the
“Loan Agreement”) between Aton Ventures Fund Ltd. (the “Lender”) and
Canyon Copper Corp. (the “Borrower”) is made and entered into effective
as of the 30th day of November, 2007 (the "Effective Date"), between the
Borrower and the Lender.

WHEREAS:

A.      The Borrower and the Lender
entered into the Loan Agreement whereby the Lender agreed to loan $250,000 to
the Borrower (the “Loan”).

B.      The Lender has agreed to
extend the term of the Loan to January 12, 2009 on the terms and conditions set
out herein.

NOW, THEREFORE, in consideration of the premises
contained herein and the sum of $10.00 paid by the Borrower to the Lender, the
receipt and sufficiency of which are hereby acknowledged, the parties agree to
amend the terms of the Loan Agreement as follows:

	1. 	
      Definitions. Capitalized terms used in this
      Agreement shall have the same meaning as specified in the Loan Agreement
      unless the context clearly indicates the contrary.

	 	 
	2. 	
      Amendment. The Loan Agreement is hereby amended as
      follows:

	 	(i) 	
      The term “Maturity Date” is replaced in its entirety with
      the following: 

	 	  	
       

	 	  	
      “Maturity Date” means January 12, 2009; 

	 	  	
       

	 	(ii) 	
      Section 2.1 of the Loan Agreement is replaced in its
      entirety with the following: 

	 	  	
       

			
      “2.1 “Loan and Repayment. The Lender hereby agrees
      to lend to the Borrower the Principal Sum of $250,000 (U.S.). The Loan
      shall be made in United States currency and shall be repaid by the
      Borrower on or before January 12, 2009.” 

	 	  	
       

	 	(iii) 	
      Section 7.1 of the Loan Agreement is replaced in its
      entirety with the following: 

	 	  	
       

			
      “7.1 The Lender may at its option, at any time prior to
      January 12, 2009, convert all or any portion of the Principal Sum into
      that number of fully-paid and non-assessable shares of common stock of the
      Borrower (the “Conversion Shares”) as shall be equal to the Principal Sum
      at a conversion rate which shall be the lesser of $0.30 U.S. per share or
      the closing price of the Borrower’s shares on the Over-the-Counter
      Bulletin Board on the business day preceding the date that the Borrower
      provides notice of conversion to the Borrower (the “Notice of
      Conversion”). Upon receipt of the Notice of Conversion, the Borrower shall
      issue for no additional consideration one half of a share purchase warrant
      (each a “Warrant”) for each Conversion Share issued by the Borrower to the
      Lender. Each whole Warrant shall entitle the Lender to purchase one
      additional share of the Borrower’s common stock for a period of one year
      from the date of issuance, at a price of $0.40 per share.” 

	 	  	
       

		(iv) 	
      The Promissory Note evidencing the Loan Agreement is
      hereby replaced in its entirety with the Promissory Note attached hereto
      as Schedule “A” to this Agreement. 

	3. 	
      No Other Modification. The parties confirm that
      the terms, covenants and conditions of the Assignment Agreement remain
      unchanged and in full force and effect, except as modified by this
      Agreement.

2

	4. 	
      Counterparts. This Agreement may be executed in
      two or more counterparts, each of which shall constitute an original, but
      all of which, when taken together, shall constitute but one instrument,
      and shall become effective when one or more counterparts have been signed
      by each party hereto and delivered to the other parties.

	 	 
	5. 	
      Successors and Assigns. Except as otherwise
      expressly provided herein, the provisions hereof shall inure to the
      benefit of, and be binding upon, the successors, assigns, heirs, executors
      and administrators of the parties hereto.

	 	 
	6. 	
      Entire Agreement. This Agreement constitutes the
      full and entire understanding and agreement between the parties with
      regard to the subject hereof.

IN WITNESS WHEREOF, the parties have duly executed and
delivered this Agreement as of the date first written above.

THE BORROWER:

CANYON COPPER CORP. 
by its authorized signatory:

	/s/ Kurt
      Bordian 	 
	Kurt Bordian 	 

THE LENDER:

ATON VENTURES FUND LTD. 
by its authorized
signatory:

	/s/ Dr. Werner
      Keicher 	 
	Dr. Werner Keicher 	 

Schedule “A”

Promissory Note

4

CONVERTIBLE PROMISSORY NOTE

	EXECUTED BY: 	Canyon Copper Corp. (the "Borrower") 
	 	 
	IN FAVOUR OF: 	Aton Ventures Fund Ltd. (the "Lender") 
	 	 
	PRINCIPAL AMOUNT: 	$250,000 (U.S.) 
	 	 
	DATE OF EXECUTION: 	September 12, 2006 
	 	 
	PLACE OF EXECUTION: 	Vancouver, BC, Canada 

FOR VALUE RECEIVED the Borrower hereby promises to pay
to or to the order of the Lender on January 12, 2009, the principal sum of
$250,000 (U.S.), together with interest thereon at the rate of 8% per annum,
both before and after maturity from the date hereof.

The Lender may at its option, at any time prior to January 12,
2009, convert all or any portion of the principal sum into that number of
fully-paid and non-assessable shares of common stock of the Borrower (the
“Conversion Shares”) as shall be equal to the principal sum at a conversion rate
which shall be the lesser of $0.30 U.S. per share or the closing price of the
Borrower’s shares on the Over-the-Counter Bulletin Board on the business day
preceding the date that the Borrower provides notice of conversion hereunder.
Upon exercise of the Lender’s conversion rights hereunder, the Lender shall
receive for no additional consideration one half of a share purchase warrant
(each a “Warrant”) for each Conversion Share issued by the Borrower to the
Lender. Each whole Warrant shall entitle the Lender to purchase one additional
share of the Borrower’s common stock for a period of one year from the date of
issuance, at a price of $0.40 per share.

The Borrower waives presentment, demand, notice, protest and
notice of dishonour and all other demands and notices in connection with the
delivery, acceptance, performance, default or enforcement of this Promissory
Note.

The Borrower agrees this Promissory Note may be negotiated,
assigned, discounted, or pledged by the Lender and in every case payment will be
made to the holder of this Promissory Note instead of the Lender upon notice
being given by the holder to the undersigned, and no holder of this Promissory
Note will be affected by the state of accounts between the undersigned and the
Lender or by any equities existing between the undersigned and the Lender and
will be deemed to be a holder in due course and for the value of the Promissory
Note held by him.

DATED at Vancouver, BC this 30th day of November, 2007.

CANYON COPPER CORP. 
by its authorized signatory:

________________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}]]